EX-23.1 3 brhc10042829_ex23-1.htm EXHIBIT 23.1
Exhibit 23.1


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We have issued our report dated March 22, 2022, with respect to the consolidated financial statements of Caladrius Biosciences, Inc. (now known as Lisata Therapeutics, Inc.) included in the Annual Report on Form 10-K for the year ended December 31, 2021, which is incorporated by reference in this Registration Statement. We consent to the incorporation by reference of the aforementioned report in this Registration Statement.
 

/s/ GRANT THORNTON LLP
 
New York, New York
October 17, 2022